Duplication of the mutant RET allele in trisomy 10 or loss of the wild-type allele in multiple endocrine neoplasia type 2-associated pheochromocytomas.

Inherited mutations of the RET proto-oncogene are tumorigenic in patients with multiple endocrine neoplasia type 2 (MEN 2). However, it is not understood why only few of the affected cells in the target organs develop into tumors. Genetic analysis of nine pheochromocytomas from five unrelated patients with MEN 2 showed either duplication of the mutant RET allele in trisomy 10 or loss of the wild-type RET allele. Our results suggest a "second hit" causing a dominant effect of the mutant RET allele, through either duplication of the mutant allele or loss of the wild-type allele, as a possible mechanism for pheochromocytoma tumorigenesis in patients with MEN 2.

[1]  N. Berger,et al.  RET rearrangements in papillary thyroid carcinomas and adenomas detected by interphase FISH , 2000, Cytogenetic and Genome Research.

[2]  L. Liotta,et al.  Constitutional von Hippel-Lindau (VHL) gene deletions detected in VHL families by fluorescence in situ hybridization. , 1999, Cancer research.

[3]  B. Ponder,et al.  Endocrine Neoplasia Type 2 Syndrome Mutations in the Multiple ret The Phenotypes Associated with Updated Version , 2007 .

[4]  K. Kinzler,et al.  Genetic instabilities in human cancers , 1998, Nature.

[5]  W. Marston Linehan,et al.  Trisomy 7-harbouring non-random duplication of the mutant MET allele in hereditary papillary renal carcinomas , 1998, Nature Genetics.

[6]  C. Eng.  Seminars in medicine of the Beth Israel Hospital, Boston. The RET proto-oncogene in multiple endocrine neoplasia type 2 and Hirschsprung's disease. , 1996, New England Journal of Medicine.

[7]  T. Ishikawa,et al.  Expression of the ret proto‐oncogene product in human normal and neoplastic tissues of neural crest origin , 1994, The Journal of pathology.

[8]  D. Clayton,et al.  Specific mutations of the RET proto-oncogene are related to disease phenotype in MEN 2A and FMTC , 1994, Nature Genetics.

[9]  C. Mathew,et al.  Genetic events in tumour initiation and progression in multiple endocrine neoplasia type 2 , 1993, Genes, chromosomes & cancer.

[10]  C. Conti,et al.  Nonrandom duplication of the chromosome bearing a mutated Ha-ras-1 allele in mouse skin tumors. , 1990, Proceedings of the National Academy of Sciences of the United States of America.

[11]  R. Harris,et al.  Genetics of Human Cancer , 1977, British Journal of Cancer.